<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The diagnosis of splenic marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMZL</z:e>) is frequently a challenge, due to its lack of specific histological features and immunophenotypic markers, and the existence of other poorly characterized splenic <z:hpo ids='HP_0002665'>lymphomas</z:hpo> defying classification </plain></SENT>
<SENT sid="1" pm="."><plain>Moreover, the clinical outcome of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMZL</z:e> is variable, with 30% of cases pursuing an aggressive clinical course, the prediction of which remains problematic </plain></SENT>
<SENT sid="2" pm="."><plain>Thus, there is a real need for biomarkers in the diagnosis and prognostication of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMZL</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>To search for genetic markers, we comprehensively investigated the genomic profile, TP53 abnormalities, and immunoglobulin heavy gene (IGH) mutation in a large cohort of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMZLs</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>1 Mb resolution array comparative genomic hybridization (aCGH) on 25 SMZLs identified 7q32 deletion (44%) as the most frequent copy number change, followed by gains of 3q (32%), 8q (20%), 9q34 (20%), 12q23-24 (8%), and chromosome 18 (12%), and losses of 6q (16%), 8p (12%), and 17p (8%) </plain></SENT>
<SENT sid="5" pm="."><plain>High-resolution chromosome 7 tile-path aCGH on 17 SMZLs with 7q32 deletion identified by 1 Mb aCGH or interphase FISH screening mapped the minimal common deletion to a 3 Mb region at 7q32.1-32.2 </plain></SENT>
<SENT sid="6" pm="."><plain>Although it is not yet possible to identify the genes targeted by the deletion, interphase FISH screening showed that the deletion was seen in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMZL</z:e> (19/56 = 34%) and splenic B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>/<z:mpath ids='MPATH_336'>leukaemia</z:mpath> unclassifiable (3/9 = 33%), but not in 39 cases of other splenic <z:hpo ids='HP_0002665'>lymphomas</z:hpo> including <z:hpo ids='HP_0011010'>chronic</z:hpo> lymphocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (n = 14), hairy cell <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (4), mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (12), follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (6), and others </plain></SENT>
<SENT sid="7" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMZL</z:e>, 7q32 deletion was inversely correlated with <z:mp ids='MP_0004027'>trisomy</z:mp> 18, but not associated with other copy number changes, TP53 abnormalities, or IGH mutation status </plain></SENT>
<SENT sid="8" pm="."><plain>None of the genetic parameters examined showed significant and independent association with overall or event-free survival </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, 7q32 deletion is a characteristic feature of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMZL</z:e>, albeit seen in <z:hpo ids='HP_0003745'>isolated cases</z:hpo> of splenic B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>/<z:mpath ids='MPATH_336'>leukaemia</z:mpath> unclassifiable, and its detection may help the differential diagnosis of splenic B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>